#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2138	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2060	195.6	0	.	n	.	0	A69G	SNP	69	69	A	281	281	G	185	G	113	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2138	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2060	195.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1662	1662	T	227	T	143	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2138	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2060	195.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	243	C	148	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3930	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	197.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1770	1770	A	207	A	131	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3930	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	197.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2404	2404	C	181	C	118	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3930	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	197.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3030	3030	T	185	T,G	119,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3930	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	197.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2478	2478	A	225	A	141	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	116	folP	852	852	99.88	folP.l15.c4.ctg.1	1505	15.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	710	712	AAA	20;20;20	A;A;A	16;16;16	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	116	folP	852	852	99.88	folP.l15.c4.ctg.1	1505	15.1	1	SNP	p	R228S	1	.	.	682	684	AGC	941	943	AGC	23;23;23	A;G;C	12;15;13	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	440	gyrA	2751	2298	100.0	gyrA.l15.c4.ctg.1	2570	29.2	1	SNP	p	S91F	0	.	.	271	273	TCC	543	545	TCC	31;32;32	T;C;C	19;21;21	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	440	gyrA	2751	2298	100.0	gyrA.l15.c4.ctg.1	2570	29.2	1	SNP	p	D95G	0	.	.	283	285	GAC	555	557	GAC	37;38;38	G;A;C	22;24;26	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	440	gyrA	2751	2298	100.0	gyrA.l15.c4.ctg.1	2570	29.2	1	SNP	p	D95N	0	.	.	283	285	GAC	555	557	GAC	37;38;38	G;A;C	22;24;26	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	440	gyrA	2751	437	99.31	gyrA.l15.c4.ctg.2	742	13.8	0	.	p	.	0	M773R	NONSYN	2317	2319	ATG	3	5	AGG	2;2;2	A;G,T;G	1;0,1;1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	513	440	gyrA	2751	437	99.31	gyrA.l15.c4.ctg.2	742	13.8	0	.	p	.	0	R774P	NONSYN	2320	2322	CGC	6	8	CCC	2;2;4	C;C,G;C	2;0,1;4	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	132	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1386	18.3	1	SNP	p	G45D	0	.	.	133	135	GGC	562	564	GGC	41;42;42	G;G,C;C	25;25,1;25	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	74	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	760	18.1	0	.	n	.	0	A197.	DEL	197	197	A	389	389	A	36	A	25	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	326	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2633	22.6	1	SNP	p	D86N	0	.	.	256	258	GAC	411	413	GAC	26;26;27	G;A;C	16;14;13	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	326	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2633	22.6	1	SNP	p	S87R	0	.	.	259	261	AGT	414	416	AGT	25;28;28	A;G;T	12;18;15	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	326	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2633	22.6	1	SNP	p	S87I	0	.	.	259	261	AGT	414	416	AGT	25;28;28	A;G;T	12;18;15	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	326	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2633	22.6	1	SNP	p	S87W	0	.	.	259	261	AGT	414	416	AGT	25;28;28	A;G;T	12;18;15	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	326	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2633	22.6	1	SNP	p	S88P	0	.	.	262	264	TCC	417	419	TCC	28;28;23	T;C;C	16;17;17	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	282	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2917	17.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1954	1956	GGC	24;24;24	G;G;C	15;14;13	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1380	1382	GCA	45;45;45	G;C;A	29;28;27	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1383	1385	ATC	43;43;43	A;T;C	28;27;27	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1395	1397	GTG	42;42;43	G;T;G	26;24;27	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1395	1397	GTG	42;42;43	G;T;G	26;24;27	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1899	1901	ACC	31;31;31	A;C;C	20;22;21	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1953	1955	GCG	19;19;19	G;C;G	15;14;12	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1953	1955	GCG	19;19;19	G;C;G	15;14;12	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2076	2078	GGC	19;19;19	G;G;C	13;15;14	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2085	2087	GGC	20;20;20	G;G;C	14;15;13	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	388	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2309	30.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2103	2105	CTG	17;16;16	C;T;G	9;8;9	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	598	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	34.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1586	1588	CCG	30;30;30	C;C;G	16;18;17	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	176	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1776	17.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	10	C	6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	784	786	GAA	60;56;56	G;A;A	37;34;34	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1072	1074	GAT	29;30;30	G;A;T	23;24;22	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1195	1197	TCA	39;38;38	T;C;A	27;27;27	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1324	1326	ATC	42;41;41	A;T;C	25;21;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1336	1338	TCT	41;41;41	T;C;T	24;24;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1654	1656	GCA	25;27;23	G;C;A	19;21;17	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	1	SNP	p	G120K	1	.	.	358	360	AAG	1030	1032	AAG	28;29;30	A;A;G	18;20;20	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	1	SNP	p	D121N	0	.	.	361	363	GAC	1033	1035	GAC	30;30;30	G;A;C	18;18;19	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	260	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	2267	21.4	1	SNP	p	A121D	1	.	.	361	363	GAC	1033	1035	GAC	30;30;30	G;A;C	18;18;19	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1052	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4644	43.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1855	1857	AAT	50;52;52	A;A;T	33;34;31	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	100	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	948	20.4	1	SNP	p	V57M	1	.	.	169	171	ATG	472	474	ATG	45;43;46	A;T;G	29;28;30	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
